Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,532,569
-
Total 13F shares
-
47,790,065
-
Share change
-
+10,949,133
-
Total reported value
-
$836,364,494
-
Put/Call ratio
-
191%
-
Price per share
-
$17.50
-
Number of holders
-
117
-
Value change
-
+$203,956,820
-
Number of buys
-
67
-
Number of sells
-
39
Institutional Holders of MBX Biosciences, Inc. - Common Stock (MBX) as of Q3 2025
As of 30 Sep 2025,
MBX Biosciences, Inc. - Common Stock (MBX) was held by
117 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,790,065 shares.
The largest 10 holders included
Frazier Life Sciences Management, L.P., WELLINGTON MANAGEMENT GROUP LLP, ORBIMED ADVISORS LLC, NEA Management Company, LLC, Deep Track Capital, LP, NVP ASSOCIATES, LLC, EcoR1 Capital, LLC, Kynam Capital Management, LP, BlackRock, Inc., and VANGUARD GROUP INC.
This page lists
117
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.